What is Sensus Healthcare's market cap?

Sensus Healthcare (SRTS) has a market capitalization of $48.4M and trades on NASDAQ.

Who are Sensus Healthcare's competitors?

Sensus Healthcare's key competitors include Solventum Corporation, Healthcare Triangle, Inc. Common Stock, Phreesia, Inc., and others. These companies compete in similar markets and product categories.

Who does Sensus Healthcare partner with?

Sensus Healthcare's notable partners include RbM Services, LLC, Koplak, LLC.

What subsidiaries does Sensus Healthcare have?

Sensus Healthcare's subsidiaries include Sensus Medical Devices Ltd., Sensus Healthcare Services, LLC.

Where is Sensus Healthcare headquartered?

Sensus Healthcare is headquartered in United States of America and employs approximately 35 people. It has been publicly traded since 2016.

Sensus Healthcare

SRTS

Sensus Healthcare is a medical device company specializing in non-invasive treatments for non-melanoma skin cancer and post-surgical keloid scar prevention.

Market cap

$48.4M-44.4%

Table of contents

Earnings

Q1 2026 report

May 7, 2026

Revenue$3.4MMiss by $1.9M EPS-$0.16Miss by $0.04

Read the full report

Next report

Aug 6, 2026 (In 1 week)

Revenue estimate$4.6M

EPS estimate-$0.13

Competitors

By market cap

Fortive$19.2B+10.1%

BrightSpring Health Services, Inc.$14.1B+292%

Solventum$13.9B+9.2%

Phreesia$657.1M-59.3%

Sensus Healthcare$49.7M-43.2%

Accuray$26.8M-81.3%

AMS

American Shared Hospital Services$10.2M-40.5%

Healthcare Triangle$3.4M-85.4%

By revenue growth

BrightSpring Health Services, Inc.+28.0%

Phreesia+14.1%

Solventum-0.5%

Fortive-6.5%

By net margin

Solventum17.33%+12.8pp

Fortive12.38%-4.3pp

BrightSpring Health Services, Inc.2.27%+2.3pp

Phreesia1.85%+11.7pp

Profile

Sensus Healthcare is a medical device company specializing in non-invasive treatments for non-melanoma skin cancer and post-surgical keloid scar prevention. The company utilizes proprietary low-energy superficial radiation therapy (SRT) technology to provide a painless, non-scarring alternative to surgical procedures. Its core value proposition centers on improving practice economics for dermatologists and oncologists while enhancing cosmetic outcomes for patients.

Competitive position

Sensus is a leading provider of superficial radiation therapy technology, positioning itself as a cost-effective and less invasive alternative to traditional surgery and large-scale linear accelerators.

GeographiesUnited States, China, European Union, United Kingdom, Russia

Customer segmentsPrivate medical practices, Hospitals, Specialized clinics

Business modelEquipment manufacturing, Revenue share, Subscription services, Cloud-based SaaS

SuppliersThird-party contract manufacturers, Specialized X-ray tube suppliers, Electronic component providers

CustomersDermatologists, Radiation oncologists, Plastic surgeons, Medical device distributors

CountryUnited States of America

Listed2016

Employees35.0

CEOJoseph C. Sardano

SectorHealthcare

IndustryMedical - Devices

Websitesensushealthcare.com

FilingsSEC EDGAR

Questions, answered.

What is Sensus Healthcare's market cap?: Sensus Healthcare (SRTS) has a market capitalization of $48.4M and trades on NASDAQ.
Who are Sensus Healthcare's competitors?: Sensus Healthcare's key competitors include Solventum Corporation, Healthcare Triangle, Inc. Common Stock, Phreesia, Inc., and others. These companies compete in similar markets and product categories.
Who does Sensus Healthcare partner with?: Sensus Healthcare's notable partners include RbM Services, LLC, Koplak, LLC.
What subsidiaries does Sensus Healthcare have?: Sensus Healthcare's subsidiaries include Sensus Medical Devices Ltd., Sensus Healthcare Services, LLC.
Where is Sensus Healthcare headquartered?: Sensus Healthcare is headquartered in United States of America and employs approximately 35 people. It has been publicly traded since 2016.